Market Overview

Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROA

Share:
Related CRL
Mid-Morning Market Update: Markets Open Higher; Time Warner Posts Mixed Q4 Results
Earnings Scheduled For February 10, 2016
Charles River Laboratories International's (CRL) CEO Jim Foster on Q4 2015 Results - Earnings Call Transcript (Seeking Alpha)
Related SHP
ShangPharma Announces Completion of Merger
ShangPharma Shareholders Approve Merger Agreement

Below are the top biotechnology stocks on the NYSE in terms of return on assets.

The trailing-twelve-month return on assets at Charles River Laboratories International (NYSE: CRL) is 7.63%. Charles River Laboratories' operating margin for the same period is 16.89%.

The trailing-twelve-month return on assets at Emergent BioSolutions (NYSE: EBS) is 7.42%. Emergent BioSolutions' revenue for the same period is $295.23 million.

The trailing-twelve-month return on assets at Cambrex (NYSE: CBM) is 6.20%. Cambrex had $33.52 million in total cash for the recent quarter.

The trailing-twelve-month return on assets at ShangPharma (NYSE: SHP) is 2.26%. ShangPharma's PEG ratio is 1.20.

Posted-In: Biotechnology Industry Highest ROA NYSETrading Ideas

 

Related Articles (CBM + CRL)

View Comments and Join the Discussion!

Get Benzinga's Newsletters